Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jun 1;126(11):2713-2714.
doi: 10.1002/cncr.32768. Epub 2020 Feb 19.

Helping patients to understand terrifying news: Addressing the inner lives of physicians and extending beyond what we know

Kah Poh Loh  1 , Supriya G Mohile  1 , Ronald M Epstein  2 , Paul R Duberstein  3
Affiliations
Comment

Helping patients to understand terrifying news: Addressing the inner lives of physicians and extending beyond what we know

Kah Poh Loh et al. Cancer. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST DISCLOSURES

Kah Poh Loh serves as a consultant to Pfizer and Seattle Genetics. Supriya G. Mohile has served as a consultant to Seattle Genetics and has received research funding from Carevive for other projects. The other authors made no disclosures.

Comment in

Comment on

References

    1. Al-Samkari H Striving for full disclosure—an intergenerational challenge. Cancer. 2020;126. - PubMed
    1. Abernethy ER, Campbell GP, Pentz RD. Why many oncologists fail to share accurate prognoses: they care deeply for their patients. Cancer. 2020;126. - PMC - PubMed
    1. Loh KP, Mohile SG, Lund JL, et al. Beliefs about advanced cancer curability in older patients, their caregivers, and oncologists. Oncologist. 2019;24:e292–e302. - PMC - PubMed
    1. Epstein RM, Duberstein PR, Fenton JJ, et al. Effect of a patient- centered communication intervention on oncologist-patient communication, quality of life, and health care utilization in advanced cancer: the VOICE randomized clinical trial. JAMA Oncol. 2017;3:92–100. - PMC - PubMed
    1. Taniyama TK, Hashimoto K, Katsumata N, et al. Can oncologists predict survival for patients with progressive disease after standard chemo-therapies? Curr Oncol. 2014;21:84–90. - PMC - PubMed